ATG-010
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for ATG-010, covering 2021-08-10 to 2026-08-10. Get the full timeline:
Most recent: Clinical Trial Results: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) [Phase 3]